Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document.

Almudena Aguilera-Saborido, Enrique Mercader Cidoncha, María Rosa Bella-Cueto, Isabel Gómez Muriel, José Vicente Méndez Monter, Jorge Gorrín Ramos, María Eugenia Torregrosa, Nieves López Lazareno, Jorge Francisco Gómez Cerezo, Patricia Martín Rojas-Marcos, Paola Parra Ramírez, Jorge Gabriel Ruiz-Sánchez, Marta Araujo-Castro, Esteban Poch, Felicia A Hanzu, Isabelle Runkle, Anna Oliveras, Josep Oriola

Journal: Endocrine 2024;85(2):532-544

PMID: 38507182

Abstract

Primary aldosteronism (PA) is the most frequent cause of secondary hypertension and is associated with a higher cardiometabolic risk than essential hypertension. The aim of this consensus is to provide practical clinical recommendations for its surgical and medical treatment, pathology study and biochemical and clinical follow-up, as well as for the approach in special situations like advanced age, pregnancy and chronic kidney disease, from a multidisciplinary perspective, in a nominal group consensus approach of experts from the Spanish Society of Endocrinology and Nutrition (SEEN), Spanish Society of Cardiology (SEC), Spanish Society of Nephrology (SEN), Spanish Society of Internal Medicine (SEMI), Spanish Radiology Society (SERAM), Spanish Society of Vascular and Interventional Radiology (SERVEI), Spanish Society of Laboratory Medicine (SEQC(ML)), Spanish Society of Anatomic-Pathology and Spanish Association of Surgeons (AEC).

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Address: Endocrinology & Nutrition Department. Hospital Universitario Ramón y Cajal. Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), University of Alcalá, Madrid, Spain. [email protected].; Endocrinology & Nutrition Department. Hospital Universitario Fundación Jiménez Díaz, Health Research Institute-Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain.; Endocrinology & Nutrition Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Cardiology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Internal Medicine, Hospital Universitario Infanta Sofía, Madrid, Spain.; Biochemical Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.; Biochemical Department, Hospital General Universitario Dr. Balmis de Alicante, Alicante, Spain.; Biochemical department, Laboratori de Referència de Catalunya, Barcelona, Spain.; Biochemistry and Molecular Genetics Department. CDB. Hospital Clínic, University of Barcelona, Barcelona, Spain.; Nephrology Department. Hospital Clinic. IDIBAPS, University of Barcelona, Barcelona, Spain.; Nephrology Department, Hospital del Mar Universitat Pompeu Fabra, Barcelona, Spain.; Vascular and Interventional Radiology Department, Hospital Clínico San Carlos, Madrid, Spain.; Radiology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Pathology Department, Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA). Universitat Autònoma de Barcelona. Sabadell. ES, Barcelona, Spain.; General Surgery. Hospital General Universitario Gregorio Marañón, Fellow European Board of Surgery -Endocrine Surgery, Madrid, Spain.; Endocrinology and Nutrition Department, Hospital Clinico San Carlos Madrid, Madrid, Spain.; Endocrinology & Nutrition Department. Hospital Clinic. IDIBAPS, University of Barcelona, Barcelona, Spain. [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.